COMMUNIQUÉS West-GlobeNewswire
-
Nanox.ARC X Digital Advanced 3D imaging built for access and powered by innovation Wins 2026 Red Dot Award for Product Design
16/04/2026 -
CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
16/04/2026 -
Helus Pharma Strengthens Medical Leadership by Appointing Dr. Ken Kramer as Senior Vice President, Medical Affairs
16/04/2026 -
Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress
16/04/2026 -
Hemp Hop’s First 420 Deals in Houston, TX - Buy 3 Get 1 Free 2026
16/04/2026 -
Nearly 4 in 10 women are missing vaginal bacteria linked to fertility
16/04/2026 -
Medera Receives FDA Fast Track Designation for Gene Therapy Targeting Duchenne Muscular Dystrophy-Associated Cardiomyopathy
16/04/2026 -
Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026
16/04/2026 -
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
16/04/2026 -
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2026
16/04/2026 -
Soleo Health Appoints Joy Rowan as New Senior Vice President of Sales to Drive Strategic Growth Initiatives
16/04/2026 -
Wellcome Leap Announces $2 Million Prize in $50 Million Quantum for Bio Challenge Program
16/04/2026 -
VTAK Definitive Agreement to Acquire 100% of Fly Flyte Inc. Obtains Shareholder Approval
16/04/2026 -
Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference
16/04/2026 -
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
16/04/2026 -
Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure
16/04/2026 -
Roquette Successfully Prices its Hybrid Notes Issuance for an Amount of 600 million Euros
16/04/2026 -
CancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs
16/04/2026 -
Roquette réalise avec succès son émission obligataire hybride, pour un montant de 600 millions d'euros
16/04/2026
Pages